Malarone



Indications and Reactions:

Role Indications Reactions
Primary
Malaria Prophylaxis 54.5%
Prophylaxis 13.5%
Drug Use For Unknown Indication 12.0%
Malaria 9.1%
Product Used For Unknown Indication 3.6%
Hypertension 1.1%
Foreign Travel 0.8%
Contraception 0.6%
Hiv Infection 0.6%
Plasmodium Falciparum Infection 0.6%
Arrhythmia 0.4%
Atrial Fibrillation 0.4%
Babesiosis 0.4%
Blood Pressure 0.4%
Depression 0.4%
Epilepsy 0.4%
Anxiety 0.3%
Bipolar Disorder 0.3%
Blood Cholesterol Increased 0.3%
Lyme Disease 0.3%
Vomiting 17.8%
Pyrexia 8.5%
Urticaria 8.0%
Weight Decreased 6.8%
Rash 5.9%
Malaria 5.4%
Drug Exposure During Pregnancy 4.6%
Nausea 4.6%
Thrombocytopenia 4.1%
Diarrhoea 3.9%
Alopecia 3.4%
Pharmaceutical Product Complaint 3.4%
Abnormal Dreams 3.2%
Malaise 3.2%
Mouth Ulceration 3.2%
Treatment Noncompliance 3.2%
Tachycardia 2.9%
Headache 2.7%
Syncope 2.7%
Psychotic Disorder 2.4%
Secondary
Product Used For Unknown Indication 20.7%
Malaria Prophylaxis 17.7%
Drug Use For Unknown Indication 12.2%
Prophylaxis 9.1%
Maternal Exposure Timing Unspecified 6.1%
Drug Exposure During Pregnancy 5.5%
Malaria 4.3%
Multiple Myeloma 4.3%
Pain 2.4%
Psoriasis 2.4%
Urinary Tract Infection 2.4%
Crohn's Disease 1.8%
Hiv Infection 1.8%
Hiv Test Positive 1.8%
Osteoporosis 1.8%
Hyperlipidaemia 1.2%
Hypertension 1.2%
Intervertebral Discitis 1.2%
Lyme Disease 1.2%
Analgesia 0.6%
Ototoxicity 19.6%
Drug Interaction 11.8%
Ventricular Septal Defect 9.8%
Dermatitis Acneiform 7.8%
Visual Impairment 5.9%
Hallucination 3.9%
Neuropathy 3.9%
Normal Newborn 3.9%
Poor Quality Sleep 3.9%
Rash 3.9%
Sepsis 3.9%
Spermatozoa Abnormal 3.9%
Thrombocytopenia 3.9%
Aspartate Aminotransferase Increased 2.0%
Cardiac Fibrillation 2.0%
Clostridium Test Positive 2.0%
Drug Exposure During Pregnancy 2.0%
Drug Rash With Eosinophilia And Systemic Symptoms 2.0%
Exposure During Pregnancy 2.0%
Foetal Exposure During Pregnancy 2.0%
Concomitant
Malaria Prophylaxis 18.8%
Septic Shock 10.3%
Contraception 8.5%
Product Used For Unknown Indication 8.5%
Drug Use For Unknown Indication 7.7%
Ankylosing Spondylitis 6.8%
Pain 4.3%
Hyperlipidaemia 3.4%
Osteoporosis 3.4%
Acne 2.6%
Crohn's Disease 2.6%
Deep Vein Thrombosis 2.6%
Embolism Venous 2.6%
Lyme Disease 2.6%
Malaria 2.6%
Medical Induction Of Coma 2.6%
Menorrhagia 2.6%
Plasmodium Falciparum Infection 2.6%
Premenstrual Syndrome 2.6%
Pulmonary Embolism 2.6%
Deep Vein Thrombosis 13.2%
Gallbladder Injury 7.9%
Poor Quality Sleep 7.9%
Aplasia Pure Red Cell 5.3%
Drug Ineffective 5.3%
Injury 5.3%
Pruritus Generalised 5.3%
Psychotic Disorder 5.3%
Pulmonary Embolism 5.3%
Thrombocytopenic Purpura 5.3%
Urticaria 5.3%
Visual Disturbance 5.3%
Weight Increased 5.3%
Arthralgia 2.6%
Atrial Fibrillation 2.6%
Fatigue 2.6%
Hallucination 2.6%
Headache 2.6%
Hepatitis Cholestatic 2.6%
Hepatocellular Injury 2.6%
Interacting
Product Used For Unknown Indication 85.7%
Malaria Prophylaxis 14.3%
Drug Interaction 60.0%
Dermatitis Acneiform 40.0%